Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma: Initial Experience in the United States

PURPOSE: This prospective phase II pilot study evaluated safety and efficacy of transarterial chemoembolization (TACE) with drug-eluting beads (DEBs) loaded with doxorubicin in patients with unresectable hepatocellular carcinoma (HCC). METHODS: Twenty patients with unresectable HCC (75% Child's...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer J
Auteurs principaux: Reyes, Diane K., Vossen, Josephina A., Kamel, Ihab R., Azad, Nilofer S., Wahlin, Tamara A., Torbenson, Michael S., Choti, Michael A., Geschwind, Jean-Francois H.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390059/
https://ncbi.nlm.nih.gov/pubmed/20010173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3181c5214b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires